Zogenix reported $375.46M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 640.92M 4.81M
Acura Pharmaceuticals ACUR:US 1.31M 70K
Adamas Pharmaceuticals ADMS:US 108M 7.65M
Aerie Pharmaceuticals AERI:US $ 275.95M 13.07M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Arena Pharmaceuticals ARNA:US $ 790.92M 199.52M
AstraZeneca AZN:LN 26.69B 583M
Becton, Dickinson and BDX:US $ 8838M 700M
Biogen BIIB:US $ 7162.3M 21.4M
Cardinal Health CAH:US 29.73B 1.32B
Esperion Therapeutics ESPR:US $ 170.67M 104.51M
Flexion Therapeutics FLXN:US $ 192.76M 8.64M
GlaxoSmithKline GSK:LN 18.25B 688M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
Intra Cellular Therapies ITCI:US $ 533.24M 68.06M
Marinus Pharmaceuticals MRNS:US $ 153.49M 32.57M
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Revance Therapeutics RVNC:US $ 293.88M 60.72M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Teva Pharmaceutical TEVA:IT 12.15B 668M
Zogenix ZGNX:US $ 375.46M 40.93M